According to our new research report “ Global In Vitro Diagnostic Market Analysis”, the year-on-year growth of the global IVD services industry is anticipated to accelerate in near future, on the back of strong demand for diagnostics services globally. Molecular diagnostic has emerged as an extremely vital segment of the IVD market and represents the most potential IVD segment for future. The future of molecular diagnostic market depicts the highest potential among the IVD segments. As per our report, the molecular diagnostic market is anticipated to grow at a CAGR of around 14% during 2010 - 2012.
Expansion of the molecular diagnostic market in future will be driven by products with improved specificity and sensitivity; technology that simplifies, automates, and speeds up testing; and an increase in high-quality molecular markers. Development of new technologies will be at the forefront to exploit the clinical potential of molecular diagnostics. Testing of infectious diseases has changed the horizon of molecular diagnostics market and new opportunities are emerging in the molecular pharmacogenomics and oncology fields, with the identification of new molecular and immunological targets.
Our report provides a clinical segmentation of the IVD market along with the future outlook for the segments analyzed in the report. It has carefully examined the IVD market in terms of industrial developments, competitive landscape, and regional basis to identify the potential growth segments. Under regional segmentation, the IVD market is classified into North America, Europe, and rest of the world.
Our research study contains systematically searched information and reliable statistical data of the global IVD market, with special focus on providing brief overview of traditional IVD testing markets and new emerging technological products. The report also presents an insight into prevailing trends in the regional IVD markets across the globe to comprehend the market dynamics. It also contains analysis of market size, growth; share, segmentation, and geographic distribution to facilitate clients understand opportunities and challenges before making any investment decision.
For more information visit: http://www.rncos.com/Report/IM103.htm |
